Articles tagged "Mortality"

2017 American Transplant Congress
Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.
M. Lim,¹ D. Sawinski,¹ J. Cohen,^1,2 B. Weiss,^3,4 J. Hogan,^1,3 L. Dember.^1,3
¹Renal, Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA; ²Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ³Penn Amyloidosis Program, Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; ⁴Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
Background: Data on patient and graft outcomes of kidney transplant recipients with end stage renal disease (ESRD) from systemic amyloidosis is scarce. Methods: We performed…
2017 American Transplant Congress
Trends in Liver Transplantation Among Older Adults with ESLD.
C. Haugen,¹ Q. Huang,² M. Pozo,¹ M. McAdams-DeMarco,² D. Segev.^1,2
¹Surgery, JHU, Baltimore; ²Epidemiology, JHU, Baltimore
As the population ages and as the average age of liver transplant (LT) waitlist candidates increases, understanding of the trends and outcomes is imperative for…
2017 American Transplant Congress
The Relationship Between Frailty and Decreased Physical Performance with Death on the Kidney Transplant Waiting List.
E. Lorenz, F. Cosio, S. Bernard, S. Bogard, B. Bjerke, E. Geissler, S. Hanna, W. Kremers, M. Stegall, A. Cheville, N. LeBrasseur.
Mayo Clinic, Rochester
Background: Frailty and decreased physical performance are associated with poor outcomes after kidney transplant. Less is known about their relationship with pre-transplant outcomes. The aim…
2017 American Transplant Congress
Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15.
K. Atiemo,¹ H. Maddur,¹ L. Zhao,¹ A. Skaro,² S. Montag,¹ L. VanWagner,¹ S. Goel,¹ A. Kho,¹ R. Kang,¹ J. Holl,¹ M. Abecassis,¹ J. Levitsky,¹ L. Kulik,¹ D. Ladner.¹
¹Northwestern University Transplant Research Collaborative, Chicago; ²London Health Sciences Center, London, ON, Canada
Introduction:Subpopulations of patients with liver cirrhosis exist for whom the Model for End-Stage Liver Disease Sodium Score (MELDNa) is suboptimal for mortality prediction and who…
2017 American Transplant Congress
Factors Associated with Death or Transplant in Low-MELD Patients.
A. Harper,¹ E. Edwards,¹ J. Heimbach.²
¹Research, UNOS, Richmond, VA; ²Surgery, Mayo Clinic, Rochester, MN
Background. The Model for End-stage Liver Disease (MELD) score is a good discriminator of 3-month mortality in patients awaiting a liver transplant. Previous research showed…
2017 American Transplant Congress
Post-Transplant Graft Function Is Associated with Major Cardiovascular Events in Kidney Transplant Recipients: A Multicenter Cohort Study.
J. Park,¹ Y. Kim,² S. Yang,³ S. Park,² S.-K. Park,⁴ D. Han,⁵ Y. Kim,² Y. Kim,⁵ J. Lee.⁶
¹Department of Internal Medicine, Dongguk University Ilsan Hospital, Gyeonggi-do, Korea; ²Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ³Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; ⁴Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; ⁵Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; ⁶Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea
Background: Reduced kidney function is an independent risk factor for cardiovascular disease in the general population. However, the association between post-transplantation graft function and subsequent…
2017 American Transplant Congress
Renal Outcomes Following Intestinal Transplantation.
C. Puttarajappa,¹ A. Humar,¹ S. Hariharan,¹ R. Cruz Jr,¹ A. Ganoza,¹ D. Landsittel,^1,3 X. Gao,³ M. Bhattarai,¹ H. Sogawa.^1,2
¹Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA; ²Abdominal Transplant & Hepatobiliary Surgery, New York Medical College/ Westchester Medical Center, Valhalla, NY; ³Section on Biomarkers and Prediction Modeling, University of Pittsburgh, Pittsburgh, PA
Purpose: Single center study of Intestinal Transplant recipients to evaluate epidemiology of dialysis and renal transplantation(RT) following Intestinal transplantation(IT).Methods: 288 adult patients who underwent first…
2017 American Transplant Congress
Impact of Body Mass Index and Waist Circumference in Kidney Transplant Recipients.
J.-E. Serre, M. Huet, I. Scwarc, V. Pernin, M. Le Quintrec, G. Mourad.
Department of Nephrology, University Hospital of Montpellier, Montpellier, France, Metropolitan
Introduction: The impact of obesity defined by a body mass index [BMI] > 30 kg/m[sup2] on kidney allograft outcomes remains controversial. The use of BMI…
2017 American Transplant Congress
Higher Mortality Among Candidates Who Refused Increased-Infectious Risk Kidney Offers.
M. Bowring, L. Kucirka, A. Massie, C. Holscher, D. Segev.
JHU, Baltimore
Increased infectious risk donors (IRD) are younger and healthier than most deceased donors, but IRD kidneys are discarded at higher rates despite potential benefit to…
2017 American Transplant Congress
Muscle Mass Is Predictive of Mortality in Obese Renal Transplant Patients.
J. Souweine,^1,3 M. Le Quintrec,¹ I. Szwarc,¹ V. Pernin,¹ G. Mourad,¹ J. Cristol,^2,3 J. Serre.¹
¹Nephrology, University Hospital of Montpellier, Montpellier, France; ²Biochemistry, University Hospital of Montpellier, Montpellier, France; ³PhyMedExp, UMR CNRS 9214, INSERM U1046, University Hospital of Montpellier, Montpellier, France
Introduction: The impact of obesity (body mass index [BMI] > 30 kg/m[sup2]) on kidney allograft outcomes is controversial. Recent studies found that obesity does not…